Nicholas Maestas - 12 Jul 2021 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
VP of Strategy and Finance
Signature
/s/ Pierre Lorenzo, attorney-in-fact for Nicholas Maestas
Issuer symbol
TPST
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
14 Jul 2021, 16:27:15 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +23,225 $0.000000 23,225 12 Jul 2021 Common Stock 23,225 $24.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying this option vest on July 12, 2022, and the remaining shares vest in a series of 36 equal monthly installments thereafter, subject to the reporting person's continued service.